STOCK TITAN

[D] CYBIN INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
D

Cybin Inc. (CYBN) filed a new Form D for an exempt offering under Rule 506(b). The notice covers stock options exercisable at CAD$8.39 per share, vesting in eight quarterly tranches beginning December 31, 2025.

Total amount sold is $0 USD, with $601,865 USD remaining to be sold. The company notes the total represents the maximum potential proceeds from option exercises. The filing lists a Date of First Sale: October 1, 2025, and reports $0 in finders’ fees. The issuer is incorporated in Ontario, Canada and identifies its industry as health care/biotechnology.

Cybin Inc. (CYBN) ha presentato un nuovo Form D per un'offerta esente ai sensi della Rule 506(b). L'avviso copre stock option exercisable a CAD$8,39 per azione, vesting in otto tranche trimestrali a partire dal 31 dicembre 2025. L'importo totale venduto è $0 USD, con $601.865 USD rimanenti da vendere. L'azienda segnala che la somma totale rappresenta i proventi potenziali massimi derivanti dall'esercizio delle opzioni. Il filing riporta una Date of First Sale: 1 ottobre 2025, e segnala $0 di commissioni per intermediari. L'emittente è incorporato in Ontario, Canada e indica il suo settore come sanità/biotecnologia.
Cybin Inc. (CYBN) presentó un nuevo Form D para una oferta exenta bajo la Regla 506(b). El aviso cubre opciones sobre acciones ejercibles a CAD$8.39 por acción, que se consolidarán en ocho tramos trimestrales a partir del 31 de diciembre de 2025. El monto total vendido es de $0 USD, quedando $601,865 USD por vender. La empresa señala que el total representa los ingresos potenciales máximos por ejercicio de las opciones. El formulario indica una Fecha de Primera Venta: 1 de octubre de 2025, e informa $0 en honorarios de intermediarios. El emisor está incorporado en Ontario, Canadá y identifica su industria como cuidados de la salud/biotecnología.
Cybin Inc. (CYBN) 은 Rule 506(b)에 따른 면제 공모를 위해 새로운 Form D 를 제출했습니다. 통지는 주당 CAD$8.39 로 행사 가능한 주식 옵션을 다섯? 여덟 분할로, 2025년 12월 31일에 시작하는 8개의 분기 트랜치를 통해 권리 행사(vesting)됩니다. 총 판매 금액은 $0 USD이며, 판매 예정 잔액은 $601,865 USD입니다. 회사는 총액이 옵션 행사에서 나올 수 있는 최대 잠재 수익을 나타낸다고 밝힙니다. 제출서는 First Sale 날짜로 2025년 10월 1일을 표시하고 중개 수수료는 $0 를 보고합니다. 발행인은 온타리오주, 캐나다에 설립되었으며 산업을 헬스케어/바이오테크로 명시합니다.
Cybin Inc. (CYBN) a déposé un nouveau Form D pour une Offre exemptée en vertu de la Rule 506(b). L'avis couvre des options d'achat d'actions exerçables à CAD$8,39 par action, qui vestent en huit tranches trimestrielles à partir du 31 décembre 2025. Le montant total vendu est de 0 $ USD, avec 601 865 $ USD restant à vendre. La société note que le total représente les recettes potentielles maximales des exercices des options. Le dépôt indique une Date de la première vente : le 1 octobre 2025, et rapporte 0 $ en frais de courtier. L'émetteur est incorporé en Ontario, Canada et indique son secteur comme soins de santé/biotechnologie.
Cybin Inc. (CYBN) hat ein neues Form D für ein exemptes Angebot gemäß Rule 506(b) eingereicht. Der Hinweis deckt Aktienoptionen ab, die zu CAD$8,39 pro Aktie ausübbar sind und in acht quartalsweisen Tranchen ab dem 31. Dezember 2025 vesten. Die insgesamt verkaufte Summe beträgt $0 USD, mit $601.865 USD verbleibend zum Verkauf. Das Unternehmen gibt an, dass der Gesamtbetrag die maximal potenziellen Erlöse aus Optionsausübungen darstellt. Die Einreichung weist ein Datum des ersten Verkaufs auf: 1. Oktober 2025, und meldet $0 Finder-Gebühren. Der Emittent ist in Ontario, Kanada, eingetragen und identifiziert seine Branche als Gesundheitswesen/Biotechnologie.
سيبن إنك. (CYBN) قدمت نموذج D جديد لعرض معفى بموجب القاعدة 506(b). الإشعار يغطي خيارات الأسهم القابلة للممارسة بسعر CAD$8.39 للسهم، وتترسّخ على مدى ثمانية دفعات ربع سنوية ابتداءً من 31 ديسمبر 2025. المبلغ الإجمالي المبيع هو $0 USD، مع $601,865 USD المتبقية للبيع. وتعلن الشركة أن الإجمالي يمثل الحد الأقصى للإيرادات المحتملة من ممارسات الخيارات. يذكر الملف تاريخ أول بيع: 1 أكتوبر 2025، ويشير إلى $0 كرسوم وسيط. الجهة المُصدِرة مُدمَجة في أونتاريو، كندا وتحدد صناعتها بأنها الرعاية الصحية/التكنولوجيا الحيوية.
Cybin Inc.(CYBN)已提交新的 Form D,用于 Rule 506(b) 下的豁免发行。通知覆盖可在每股 CAD$8.39 行使的股票期权,自 2025 年 12 月 31 日起分八个季度分期归属。总销售金额为 $0 USD,尚有 $601,865 USD 待售。发行人指出总额代表期权行使的最大潜在收益。申报列出首销日期:2025 年 10 月 1 日,报告的中介费为 $0。发行人注册于加拿大安大略省,行业为医疗保健/生物技术。
Positive
  • None.
Negative
  • None.
Cybin Inc. (CYBN) ha presentato un nuovo Form D per un'offerta esente ai sensi della Rule 506(b). L'avviso copre stock option exercisable a CAD$8,39 per azione, vesting in otto tranche trimestrali a partire dal 31 dicembre 2025. L'importo totale venduto è $0 USD, con $601.865 USD rimanenti da vendere. L'azienda segnala che la somma totale rappresenta i proventi potenziali massimi derivanti dall'esercizio delle opzioni. Il filing riporta una Date of First Sale: 1 ottobre 2025, e segnala $0 di commissioni per intermediari. L'emittente è incorporato in Ontario, Canada e indica il suo settore come sanità/biotecnologia.
Cybin Inc. (CYBN) presentó un nuevo Form D para una oferta exenta bajo la Regla 506(b). El aviso cubre opciones sobre acciones ejercibles a CAD$8.39 por acción, que se consolidarán en ocho tramos trimestrales a partir del 31 de diciembre de 2025. El monto total vendido es de $0 USD, quedando $601,865 USD por vender. La empresa señala que el total representa los ingresos potenciales máximos por ejercicio de las opciones. El formulario indica una Fecha de Primera Venta: 1 de octubre de 2025, e informa $0 en honorarios de intermediarios. El emisor está incorporado en Ontario, Canadá y identifica su industria como cuidados de la salud/biotecnología.
Cybin Inc. (CYBN) 은 Rule 506(b)에 따른 면제 공모를 위해 새로운 Form D 를 제출했습니다. 통지는 주당 CAD$8.39 로 행사 가능한 주식 옵션을 다섯? 여덟 분할로, 2025년 12월 31일에 시작하는 8개의 분기 트랜치를 통해 권리 행사(vesting)됩니다. 총 판매 금액은 $0 USD이며, 판매 예정 잔액은 $601,865 USD입니다. 회사는 총액이 옵션 행사에서 나올 수 있는 최대 잠재 수익을 나타낸다고 밝힙니다. 제출서는 First Sale 날짜로 2025년 10월 1일을 표시하고 중개 수수료는 $0 를 보고합니다. 발행인은 온타리오주, 캐나다에 설립되었으며 산업을 헬스케어/바이오테크로 명시합니다.
Cybin Inc. (CYBN) a déposé un nouveau Form D pour une Offre exemptée en vertu de la Rule 506(b). L'avis couvre des options d'achat d'actions exerçables à CAD$8,39 par action, qui vestent en huit tranches trimestrielles à partir du 31 décembre 2025. Le montant total vendu est de 0 $ USD, avec 601 865 $ USD restant à vendre. La société note que le total représente les recettes potentielles maximales des exercices des options. Le dépôt indique une Date de la première vente : le 1 octobre 2025, et rapporte 0 $ en frais de courtier. L'émetteur est incorporé en Ontario, Canada et indique son secteur comme soins de santé/biotechnologie.
Cybin Inc. (CYBN) hat ein neues Form D für ein exemptes Angebot gemäß Rule 506(b) eingereicht. Der Hinweis deckt Aktienoptionen ab, die zu CAD$8,39 pro Aktie ausübbar sind und in acht quartalsweisen Tranchen ab dem 31. Dezember 2025 vesten. Die insgesamt verkaufte Summe beträgt $0 USD, mit $601.865 USD verbleibend zum Verkauf. Das Unternehmen gibt an, dass der Gesamtbetrag die maximal potenziellen Erlöse aus Optionsausübungen darstellt. Die Einreichung weist ein Datum des ersten Verkaufs auf: 1. Oktober 2025, und meldet $0 Finder-Gebühren. Der Emittent ist in Ontario, Kanada, eingetragen und identifiziert seine Branche als Gesundheitswesen/Biotechnologie.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
X None
Entity Type
0001833141
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
CYBIN INC.
Jurisdiction of Incorporation/Organization
ONTARIO, CANADA
Year of Incorporation/Organization
X Over Five Years Ago
Within Last Five Years (Specify Year)
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
CYBIN INC.
Street Address 1 Street Address 2
100 King St. West, Suite 5600
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
Toronto ONTARIO, CANADA M5X 1C9 (866) 292-4601

3. Related Persons

Last Name First Name Middle Name
So Eric
Street Address 1 Street Address 2
100 King St. West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Tziras George
Street Address 1 Street Address 2
100 King Street West Suite 560
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA V5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Fahel Gabriel
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Glavine Paul
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Cavers Greg
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Bartlone Aaron
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Firestone Theresa
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Lawson Mark
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Froese Grant
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Hoskins Eric
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
X
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
X Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-10-01 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
X Yes No

9. Type(s) of Securities Offered (select all that apply)

Equity Pooled Investment Fund Interests
Debt Tenant-in-Common Securities
X Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security X Other (describe)
Stock options exercisable at CAD$8.39 per share vesting in eight quarterly tranches beginning December 31, 2025.

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number X None
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
Street Address 1 Street Address 2
City State/Province/Country ZIP/Postal Code
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
Foreign/non-US

13. Offering and Sales Amounts

Total Offering Amount $601,865 USD
or Indefinite
Total Amount Sold $0 USD
Total Remaining to be Sold $601,865 USD
or Indefinite

Clarification of Response (if Necessary):

Total offering amount represents maximum potential proceeds from exercise of options. CAD$1.3940=USD$1.00

14. Investors

X
Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
4
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
4

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $0 USD
Estimate
Finders' Fees $0 USD
Estimate

Clarification of Response (if Necessary):

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
CYBIN INC. /s/ Greg Cavers Greg Cavers CFO 2025-10-15

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


FAQ

What did CYBN file and under which exemption?

Cybin Inc. filed a Form D for an exempt offering under Rule 506(b).

What securities are covered in Cybin’s Form D?

The notice covers stock options exercisable at CAD$8.39 per share, vesting in eight quarterly tranches starting December 31, 2025.

How much of the offering has been sold and what remains?

Total amount sold is $0 USD; $601,865 USD remains to be sold.

When did the first sale occur according to the notice?

The filing lists a Date of First Sale: October 1, 2025.

Are there any sales commissions or finders’ fees reported?

The filing reports $0 in finders’ fees.

What does the total offering amount represent?

It represents the maximum potential proceeds from the exercise of the options.
Cybin Inc

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Latest SEC Filings

CYBN Stock Data

154.66M
16.34M
98.65%
38.53%
10.87%
Biotechnology
Healthcare
Link
Canada
Toronto